TT, those who made their experiences with IMU and other Bio-Techs know that after the initial excitement - yesterday - a sp fall is very likely and quite frankly, those, who missed the 1.8c entry like me, are happy to get a chance to buy for less than 3c. In my case, the lower the better.
All pre-clinical trials are done by using animals, mostly mice. And huge deals have been signed in the US just based on that as big pharma is desperate for market share as most missed the quantum leap in oncology. That has increased the valuations of results like IVX's. And I can't stress enough the importance of the immune system activation and the memory effect. That is similar to IMU's CF33. At this stage INV043 is tested for TNBC but if suitable for more types then watch this explode.
Until then, I am happy with whatever is offered. High teens or low 3s. And like at IMU, I have the patience to wait for this one unfolding.
GLTA
IVX Price at posting:
2.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)